Effects of Ramipril and Rosiglitazone on Cardiovascular and Renal Outcomes in People With Impaired Glucose Tolerance or Impaired Fasting Glucose: Results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial

Similar Items

• Trial update: the Diabetes REduction Approaches with ramipril and rosiglitazone Medications (DREAM) trial
  by: G. Gulli
  Published: (2013-05-01)
• Incidence of diabetes following ramipril or rosiglitazone withdrawal.
  by: Investigators, D
  Published: (2011)
• Incidence of diabetes following ramipril or rosiglitazone withdrawal
  by: Holman, R, et al.
  Published: (2011)
• Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
  by: Gerstein, H, et al.
  Published: (2006)
• A Comparative Evaluation of Ramipril as Monotherapy and Combination of Ramipril with Torsemide in Hypertension
  by: Navjot Kaur, et al.
  Published: (2017-11-01)